cancer

UBC biotech spin-off raises $75M to bring cancer treatments to patients

UBC biotech spin-off raises $75M to bring cancer treatments to patients

With roots in UBC research, Alpha-9 Theranostics is developing cancer radiotherapies that target tumours while avoiding healthy tissues.

A team approach to understanding post-treatment cancer care

A team approach to understanding post-treatment cancer care

Researchers at UBCO are exploring the critical role family physicians play in post-cancer care.